store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Evixapodlin (PD-1/PD-L1-IN 7) is a human PD-1/PD-L1 protein/protein interaction inhibitor (IC50: 0.213).Evixapodlin has anticancer and antiviral activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 113.00 | |
5 mg | In stock | $ 278.00 | |
10 mg | In stock | $ 447.00 | |
25 mg | In stock | $ 847.00 | |
50 mg | In stock | $ 1,130.00 | |
100 mg | In stock | $ 1,530.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 428.00 |
Description | Evixapodlin (PD-1/PD-L1-IN 7) is a human PD-1/PD-L1 protein/protein interaction inhibitor (IC50: 0.213).Evixapodlin has anticancer and antiviral activities. |
Targets&IC50 | PD-1/PD-L1 (human):0.213 nM (IC50) |
In vitro | Evixapodlin exhibits an ability to increase the production of IFN-γ and Granzyme B in both CD8+ and CD4+ T cells in individuals with chronic hepatitis B (CHB). Additionally, Evixapodlin enhances the frequency of Granzyme B-positive cells among HBV-specific CD8+ and CD4+ T cells.[1] |
In vivo | Evixapodlin (10-50 mg/kg; intraperitoneal injection, daily, for 6 days) treatment results in over 90% occupancy of the PD-L1 target on tumor cells. Evixapodlin effectively suppresses tumor growth in a mouse colorectal tumor model (MC38) that expresses human PD-L1.[1] |
Synonyms | PD-1/PD-L1-IN 7, GS-4224 |
Molecular Weight | 691.61 |
Formula | C34H36Cl2N8O4 |
CAS No. | 2374856-75-2 |
store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45.0 mg/mL (65.1 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Evixapodlin 2374856-75-2 Apoptosis Cell Cycle/Checkpoint Immunology/Inflammation Microbiology/Virology PD-1/PD-L1 HBV Antiviral PD-1/PD-L1-IN 7 GS-4224 GS4224 GS 4224 inhibitor inhibit